AUPH - Aurinia Pharma spikes after Q3 beat; narrows guidance
2023-11-02 10:51:47 ET
More on Aurinia Pharma
- Aurinia Pharmaceuticals: Reassessing As It Gains Traction
- Aurinia Rides High On Lupkynis, But Not Without Cost (Rating Upgrade)
- Aurinia Pharma Q3 2023 Earnings Preview
- Aurinia reaches truce with major shareholder in new board appointment
- Seeking Alpha’s Quant Rating on Aurinia Pharma
For further details see:
Aurinia Pharma spikes after Q3 beat; narrows guidance